Skip to main content

Histamine has a strong impact on tight junction regulation of intestinal cells

In previous posts was mentioned that the fecal body odor seems to be related histamine degradation deficiency.

What impact does that have?

It looks like histamine concentrations are highly important for the tight junction regulation of intestinal cells.

The tight junctions are important for the direct paracellular transport of electrolytes into the blood without transition through the intestinal cell metabolism.

Increased open tight junctions will further lead to an increased surface area of the intestinal cells and are as a result a strong regulator of passing amines and their level of being processed.


One of the regulation relevant receptor for the tight junctions is the H1 receptor.

When mast cells e.g. get active they release histamine to open those tight junctions.

So a relation to food allergies as a initial trigger seems to be a possible factor with an upfollowing malregulation of the histamine concentrations.

The malregulation would be based on the increased histamine levels passing through the too wide opened tight junctions and the downregulation of HNMT enzyme by higher acetate electrolytes.

If we look at the indole chemical it is important to know that recent research has shown that indole acts as an tight junction closing regulator.
This makes sense since the area were the intestinal cells have to down regulate the amount of passing chemicals is variable and dependant of the daily fermentation levels of the digested foods.
So the body can adapt the intestinal cells with tight junction regulation very good.

As an impact on body odor sufferers can the negative overregulation of tight junction proteins bein named.

All major body odor types seems to have that symptom in common.

Comments

  1. Hi, I suffer from both Mast cell activation syndrome and bromhidrosis, I find this very intresting, actually It's the only one research I've found that connect these problems. I hope you will find out more :)

    ReplyDelete

Post a Comment

Popular posts from this blog

Glutamine and Glutamate seems to increase butyrate production in the large intestinal tract

Glutamine and its counterpart glutamate seems to increase the butyrate production in the intestinal tract. Butyrates show a biting or pungeant, light sweat like smell. This strengthens the view that the tight junction sealing is dominated by metabolite pathways that present in one or the other way highly smelling chemical compounds the body is forced to absorb to counter regulate its deregulated energy metabolism in the intestinal tract .

Bromhidrosis TSH+: Diet protocol + nystatin, nigella sativa + h1 receptor antagonists + medicinal clay improves body odor condition

In our explorative case we were further able to improve the diet protocol as well as finding a new drug/supplement  composition. We are taking advantage of following over the counter drugs/supplements: - Nystatin - Nigella sativa (black cumin) capsules - H1 receptor antagonists (loratadin) - medicinal clay The diet protocol was taken from: https://drive.google.com/folderview?id=19hmatFJPil1svc9DRyuRn3S9rUF7yqH_ Dosages (daily) applied were like the following: nystatin: 6x pills (3x at morning, 3x at evening) nigella sativa: >10000mg (5x 400mg capsules before every meal, 5 meals per day) loratadin: 50mg - 100mg daily medicinal clay: 6x 6g (luvos healing earth)

Candida pathogenesis in Bromhidrosis

Our observation was that bromhidrosis patients reported slight elevated candida sp. levels in combination mit reduced enterococcus sp. in stool analysis results. The current metabolism impact for bromhidrosis seems to be sourced in a deficient acetate or propionate degrading enzyme which is part of the major ethanol degradation. The biosynthesis of ethanol is mostly based on candida sp., so we investigated into the pathogenesis of candida. The following pictures show the resulting disease model. In the case of an deficiency in the ethanol degradation pathway, the immune system shows a weakness regarding the candida sp., which shifts the microbiome towards increased candida occurence and activity. This would lead to small intestinal fungal overgrowth (SIFO) symptoms